Evaluation of Novartis Access:
An (NCD) medicine access initiative
Boston University is evaluating Novartis Access, a social business program to increase access to medicines for non-communicable diseases (NCDs) through the direct sale of NCD medicines to governments and other public-sector customers in low and lower middle income countries.
What makes this evaluation unique?
Use of multiple complementary methods such as:
- Cluster-randomized controlled trial
- Serial qualitative interviews
- Telephonic monitoring as an input into the evaluation
Explore the evaluation and related features